Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
ID: 357658Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $50K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH), through its National Center for Advancing Translational Sciences (NCATS), has announced a funding opportunity for the Limited Competition Small Grant Program (R03), aimed at supporting Clinical and Translational Science Award (CTSA) Program KL2/K12 scholars and diversity supplement recipients. This program is designed to facilitate the transition of these scholars to independent research careers by funding small, self-contained research projects that can be conducted quickly and with limited resources, ultimately addressing inefficiencies in translational science. Grants of up to $50,000 per year are available for projects lasting up to two years, with a submission deadline of January 17, 2025, and an anticipated award cycle beginning in February 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and its National Center for Advancing Translational Sciences (NCATS), announces a funding opportunity for the Limited Competition Small Grant Program (R03). This program supports NCATS Clinical and Translational Science Award (CTSA) Program KL2/K12 scholars and diversity supplement recipients, facilitating their transition to independent research careers. The funding focuses on small, self-contained research projects that can be conducted rapidly and with limited resources, aimed at tackling inefficiencies in translational science. The grants will be available for a maximum of $50,000 per year, with projects lasting up to two years. Key eligibility requirements include prior NCATS funding and specific institutional and individual qualifications. Application guidelines emphasize compliance with detailed submission instructions and highlight the importance of clear letters of support from mentors and the institution. The program aims to generate preliminary data for future research applications and to develop innovative solutions addressing challenges in health-related research. The anticipated award cycle begins in February 2025, with a submission deadline of January 17, 2025. The initiative articulates a commitment to fostering the next generation of clinical and translational science leaders while enhancing scientific understanding and health outcomes.
    Similar Opportunities
    Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program, designated as R03 Clinical Trial Optional. This funding opportunity aims to support KL2/K12 scholars and recipients of diversity and re-entry supplements in their transition to independent research roles by funding small, innovative, self-contained projects in translational science, with a maximum budget of $50,000 per year over a two-year period. The initiative is designed to enhance the capabilities of emerging researchers in addressing inefficiencies in translating research into clinical applications, engaging underrepresented populations, and improving data accessibility through innovative technologies. Applications will be accepted starting January 19, 2024, with multiple deadlines leading up to October 20, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Limited Competition Small Grant Program aimed at recipients of NIAMS K01, K08, K23, and K25 awards, providing funding opportunities to enhance their research capabilities. This program allows eligible applicants to apply for Small Grant (R03) funding, which offers up to $100,000 for a two-year period to support pilot studies, secondary data analyses, and small-scale research projects, specifically excluding clinical trials. The initiative is designed to facilitate the transition of early-career scientists to independent investigator status, ultimately encouraging them to pursue R01 grants. Interested applicants must adhere to specific application guidelines, with submission dates beginning January 19, 2025, and a complete application deadline of February 20, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Limited Competition Small Grant Program (R03) aimed at supporting current or recently completed NHLBI K01, K08, K23, and K25 awardees in enhancing their research capabilities as they transition to independent investigator roles. This funding opportunity allows eligible applicants to receive up to $75,000 per year for short-term research projects that can be completed within two years, focusing on activities such as pilot studies, proof of concept evaluations, and methodological development that generate preliminary data for future R01 applications. The program emphasizes the importance of fostering a diverse scientific workforce and is open for applications from January 13, 2023, with a closing date of January 7, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Limited Competition funding opportunity titled the Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3), aimed at enhancing translational research through collaborative efforts among multiple medical research institutions. This initiative seeks to support the development, implementation, and dissemination of innovative solutions that address urgent public health needs and promote health equity, requiring applicants to include at least three eligible organizations to foster interdisciplinary partnerships. Eligible projects can receive funding of up to $650,000 annually for a total duration of up to five years, with applications due by October 19, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-296.html.
    Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), has announced a Limited Competition Small Grant Program aimed at supporting current K01, K08, K23, and K25 award recipients. This program is designed to facilitate the transition of these early-career researchers to fully independent investigator status by providing funding for small, self-contained research projects, with grants offering up to $75,000 in direct costs per year for a maximum project period of two years. The initiative encourages applicants to demonstrate their growing independence and ability to secure future funding, particularly for R01 applications, while adhering to NIH policies regarding human subjects and clinical trials. Interested applicants must submit their proposals by September 7, 2025, and can find additional information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering funding through the Small Research Grant Program (Parent R03 Clinical Trial Not Allowed), aimed at supporting discrete research projects that can be completed within two years and require limited resources. This program encourages applications for various types of research, including pilot studies, feasibility studies, and the development of new research methodologies, while explicitly excluding clinical trials. With a funding ceiling of $50,000 per year, the program is open to a diverse range of eligible applicants, including higher education institutions, nonprofits, and government entities, particularly those representing historically underrepresented groups. Interested applicants should note that the first submission opportunity opens on January 16, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a limited competition grant opportunity for the Mentored Research Career Development Program Award under the Clinical and Translational Science Awards (CTSA) Program. This initiative aims to develop innovative career advancement programs for later-stage postdoctoral fellows and junior faculty who are committed to independent clinical and translational science research careers, facilitating their transition into leadership roles through structured mentorship and research experiences. The program is designed to enhance the clinical and translational science workforce, addressing national biomedical research needs, and encourages diversity among scholars. Eligible institutions may submit a single K12 application alongside a UM1 application, with a funding period of up to five years. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov, with the application deadline set for September 28, 2027.
    Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Heart, Lung, and Blood Institute (NHLBI), has announced a Limited Competition Small Grant Program aimed at supporting current and recently completed K01, K08, K23, and K25 award recipients. This funding opportunity, designated as RFA-HL-25-011, allows eligible applicants to secure up to $75,000 per year for projects lasting up to two years, with the goal of generating preliminary data for subsequent R01-equivalent applications. The program is particularly focused on advancing early-stage investigators towards independent research careers, emphasizing the inclusion of underrepresented groups in biomedical research. Interested applicants must adhere to strict submission guidelines via Grants.gov, with a close date for applications set for January 7, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Limited Competition Small Grant Program (R03) aimed at supporting recipients of K01, K08, K23, and K25 awards from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). This program allows eligible awardees, specifically those in their second to fourth award year who do not yet hold independent R01 grants, to request up to $100,000 in direct costs over a two-year period to enhance their research capabilities, focusing on pilot studies, methodology development, and secondary data analysis, while explicitly excluding clinical trials. The initiative is designed to foster the development of early-career scientists and strengthen the research landscape by generating additional publications and data necessary for future R01 grant applications. Interested applicants must submit their proposals by February 19, 2025, and can find more information and application guidelines at the NIH website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant under the Clinical and Translational Science Awards (CTSA) Program. This grant aims to support eligible institutions in developing and disseminating training and career support programs for individuals pursuing a PhD or equivalent research health professional degree, with a focus on fostering a diverse pool of clinical and translational scientists equipped to address pressing health needs. The program is critical for advancing research in diagnostics, therapeutics, and clinical interventions, ultimately enhancing health outcomes. Interested institutions must note that the application deadline is September 28, 2027, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-194.html.